Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Cormorant Asset Management
company
Investments
Number of Investments
Number of Lead Investments
21
3
Cormorant Asset Management has made 21 investments. Their most recent investment was on
Aug 12, 2022, when Greenlight Biosciences, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Aug 12, 2022 | Greenlight Biosciences | Post-IPO Equity | — | Agriculture | — |
| Apr 19, 2022 | Tessera Therapeutics | Series C | — | Biopharma | — |
| Feb 16, 2022 | Star Therapeutics | Series Unknown | — | — | |
| Feb 3, 2022 | Greenlight Biosciences | Post-IPO Equity | — | Agriculture | — |
| Jul 13, 2021 | Prime Medicine | Series B | — | Biotechnology | — |
| Mar 22, 2021 | EpimAb Biotherapeutics | Series C | — | Biopharma | — |
| Jan 19, 2021 | Beam Therapeutics | Post-IPO Equity | — | Biotechnology | — |
| Jan 19, 2021 | Verve Therapeutics | Series B | — | Biotechnology | — |
| Sep 28, 2020 | BioShin | Series A | — | Biotechnology | — |
| Aug 26, 2020 | Freenome | Series C | — | Biotechnology | — |
| Jun 16, 2020 | Greenlight Biosciences | Series D | — | Agriculture | — |
| Nov 13, 2019 | Avidity Biosciences | Series C | — | Biotechnology | — |
| Mar 6, 2019 | Beam Therapeutics | Series B | — | Biotechnology | — |
| Apr 25, 2018 | Corvidia | Series B | — | Biotechnology | — |
| Nov 16, 2017 | X4 Pharmaceuticals | Series B | — | Biotechnology | Yes |
| Sep 26, 2017 | Autolus | Series C | — | Biopharma | Yes |
| Sep 8, 2017 | Replimune Group | Series B | — | Biotechnology | — |
| Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Jan 19, 2016 | Twist Bioscience | Series D | — | Biotechnology | — |
| Dec 15, 2015 | X4 Pharmaceuticals | Series A | — | Biotechnology | Yes |
| Jun 22, 2015 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
